SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 223 filers reported holding SEATTLE GENETICS INC in Q2 2015. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $75,954,000 | +22.9% | 388,136 | +6.7% | 0.24% | +12.0% |
| Q2 2020 | $61,800,000 | +25.7% | 363,698 | -14.6% | 0.22% | -0.9% |
| Q1 2020 | $49,156,000 | +60.6% | 426,037 | +59.0% | 0.22% | +113.7% |
| Q4 2019 | $30,611,000 | +167.7% | 267,908 | +47.3% | 0.10% | +200.0% |
| Q1 2017 | $11,435,000 | +39.5% | 181,919 | +17.1% | 0.03% | +36.0% |
| Q4 2016 | $8,195,000 | -55.9% | 155,291 | -54.9% | 0.02% | -56.1% |
| Q3 2016 | $18,589,000 | +118.9% | 344,174 | +63.8% | 0.06% | +111.1% |
| Q2 2016 | $8,493,000 | -12.3% | 210,174 | -16.3% | 0.03% | -6.9% |
| Q3 2015 | $9,683,000 | -34.6% | 251,123 | -18.0% | 0.03% | -25.6% |
| Q2 2015 | $14,815,000 | – | 306,102 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parametrica Management Ltd | 3,581 | $248,000 | 42.18% |
| Baker Brothers Advisors | 50,057,277 | $3,464,464,000 | 23.54% |
| Lagoda Investment Management, L.P. | 76,073 | $5,265,000 | 6.10% |
| Matrix Capital Management Company, LP | 3,141,852 | $217,448,000 | 4.02% |
| DOMINI IMPACT INVESTMENTS LLC | 3,111 | $215,000 | 2.98% |
| Opus Point Partners Management, LLC | 17,901 | $1,239,000 | 1.83% |
| EMORY UNIVERSITY | 33,593 | $2,325,000 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,215,000 | 1.56% |
| Capital International Sarl | 130,400 | $9,025,000 | 1.26% |
| CAPITAL GUARDIAN TRUST CO | 1,303,961 | $90,147,000 | 1.21% |